Picton Mahoney Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$393K Buy
4,068
+698
+21% +$71.6K ﹤0.01% 790
2025
Q4
$358K Sell
3,370
-3,789
-53% -$439K ﹤0.01% 755
2025
Q3
$909K Buy
+7,159
New +$852K 0.01% 506
2016
Q1
Sell
-4,274
Closed -$118K 322
2015
Q4
$118K Buy
4,274
+1,257
+42% +$35.8K 0.01% 223
2015
Q3
$92K Buy
3,017
+1,006
+50% +$35K 0.01% 232
2015
Q2
$74K Hold
2,011
﹤0.01% 276
2015
Q1
$71K Buy
2,011
+377
+23% +$12.9K ﹤0.01% 272
2014
Q4
$50K Hold
1,634
﹤0.01% 272
2014
Q3
$48 Sell
1,634
-1,760
-52% -$53.6K ﹤0.01% 295
2014
Q2
$97 Hold
3,394
0.01% 274
2014
Q1
$97K Sell
3,394
-754
-18% -$19.6K 0.01% 314
2013
Q4
$110K Hold
4,148
0.01% 308
2013
Q3
$114K Buy
+4,148
New +$106K 0.01% 266

Other funds holding EHC

Picton Mahoney Asset Management's EHC Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its Encompass Health (EHC) stake by 21% in Q1 2026, buying an estimated $71.6K and bringing the position to 4,068 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #790.

Picton Mahoney Asset Management first reported a position in EHC in Q3 2013 and has held it in 13 quarters since. The position peaked at $909K in Q3 2025. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Picton Mahoney Asset Management held 4,068 shares of Encompass Health worth $393K as of Q1 2026.
  • Picton Mahoney Asset Management bought 698 Encompass Health shares in Q1 2026, an estimated $71.6K.
  • Encompass Health made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #790 holding.
  • Picton Mahoney Asset Management first reported a position in Encompass Health in Q3 2013 and has held it in 13 quarters since.
  • Picton Mahoney Asset Management's Encompass Health position peaked at $909K in Q3 2025.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.